Roche (Swiss: RO) announced that the U.S. Food and Drug Administration granted 510(k) clearance for its cobas c703 and cobas ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE